AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said ...

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said Datroway has secured US Food & Drug Administration approval for use in adult patients with previously treated advanced ...

"We are very excited," AstraZeneca executive vice president Ruud Dobber said in a call Monday with reporters. "The data set is very, very robust." "We've had absolute confidence in the efficacy of ...

Brushing aside a dramatic rebuke from government researchers and independent experts, AstraZeneca on Wednesday night announced that a new analysis found its COVID-19 vaccine to be 76 percent ...

AstraZeneca claimed a vaccine efficacy of 79%, but the committee said that was using outdated data. What a difference a day makes. Yesterday, scientists celebrated AstraZeneca's announcement that ...

In the statement, NIAID urged AstraZeneca to review the vaccine efficacy data and ensure its accuracy and timeliness. It was an unusual statement for the National Institute of Allergy and ...

AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said ...